Eisai
4523.T
#2024
Rank
NZ$13.84 B
Marketcap
$49.10
Share price
-0.60%
Change (1 day)
-38.90%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.54

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.89. In 2022 the company made an earnings per share (EPS) of $2.86 a decrease over its 2021 EPS that were of $12.69.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.5423.83%
2022$2.86-77.48%
2021$12.69-41.88%
2020$21.84-0.94%
2019$22.0452.59%
2018$14.45124.17%
2017$6.44-49.42%
2016$12.7437.08%
2015$9.30-11.75%
2014$10.53-3.23%
2013$10.88-18.56%
2012$13.37-15.51%
2011$15.82-3.75%
2010$16.44-1.36%
2009$16.66